1.
Bousquet J, Bousquet PJ, Godard P, Daures JP: The public health implications of asthma.Bull World Health Org 2005, 83:548-554.
2.
Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA dissemination committee report.Allergy 2004, 59:469-478.
3.
Verlato G, Corsico A, Villani S, Cerveri I, Migliore E, Accordini S, Carolei A, Piccioni P, Bugiani M, Lo Cascio V, Marinoni A, Poli A, de Marco R: Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian Study.J Allergy Clin Immunol 2003, 111:1232-1233.
4.
Woolcock AJ, Peat JK: Evidence for the increase in asthma worldwide.In The Rising Trend in Asthma. Ciba Foundation Symposium 206. Chichester, UK: Wiley; 1997:122-134.
5.
Bousquet J, Ndiaye M, Alt-Khaled N, Annesi-Maesano I, Vignola AM: Management of chronic respiratory and allergic diseases in developing countries. Focus on sub-saharan Africa.Allergy 2003, 58:265-283.
6.
Bielory LB, Lupoli K: Herbal intervention in asthma and allergy.J Asthma 1999, 36:1-65.
7.
Markham AW, Wilkinson JM: Complimentary and alternative medicines (CAM) in the management of asthma: An examination of the evidence.J Asthma 2004, 41:131-139.
8.
Huntley A, Ernst E: Herbal medicines for asthma: a systematic review.Thorax 2000, 55:925-929.
9.
Bensky D, Gamble A: Chinese herbal medicine.In Materia Medica. Seattle : Eastland Press; 1993:360-361.
10.
Dai Y, Kon JP, Liu LH: Antiallergic effect of aqueous extract of Wu-hu-tang.J Ethnopharmacol 1997, 55:127-132.
11.
Dorsch W, Wagner H: New antiasthmatic drugs from traditional medicine.Int Arch Allergy Appl Immunol 1991, 94:262-265.
12.
Hsu CH, Lu CM, Chang TT: Efficacy and safety of modified Mai-Men-Dong-Tang for treatment of allergic asthma.Ped Allergy Immunol 2005, 16:76-81.
13.
Kubo Y, Hossain M, Horie S, Momose T, Suzuki J, Isobe M, Sekiguchi M: Effect of herbal medicine (Sho-seiryu-to and Ryo-kan-kyo-mi-shin-ge-nin-to) on human eosinophil biological function.Phytotherapy Res 1997, 11:485-489.
14.
Sakaguchi M, Iizuka A, Yuzurihara M, Ishige A, Komatsu Y, Matsumiya T, Takeda H: Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects of histamine H1 receptors and muscarinic cholinergic system in the brain.Methods Find Exp Clin Pharmacol 1996, 18:41-47.
15.
Kobayashi T, Hashimoto S, Horie T: Curcumin inhibition of Dermatophagoides farinae-induced Interleukin-5 (IL-5) and granulocyte macrophage colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics.Biochem Pharmacol 1997, 54:819-824.
16.
Shivapuri DN, Singhal SC, Prakash D: Treatment of asthma with an alcoholic extract of Tylophora indica: A cross-over, double blind study.Ann Allergy 1972, 30:407-412.
17.
Bharti AC, Takada Y, Aggarwal BB: Curcumin (Diferuloylmethane) inhibits receptor activator of NF-KB Ligand-induced NFB activation in osteoclast precursors and suppresses osteoclastogenesis.J Immunol 2004, 172:5940-5947.
18.
Bremnon P, Heinrich M: Natural products as targeted modulators of the nuclear factor-KB pathway.J Pharmacy Pharmacology 2002, 54:453-472.
19.
Skrzypczak-Jankun E, Zhon K, McCabe NP, Selman SH, Jankun J: Structure of curcumin in complex with lipoxygenase and its significance in cancer.Int J Mol Med 2003, 12:17-24.
20.
Kurup VP, Kumar A, Choi HY, Murali PS, Resnick A, Kelly KJ, Fink JN: Latex antigens induce IgE and eosinophils in mice.Int Arch Allergy Immunol 1994, 103:370-377.
21.
Thakker JC, Xia J-Q, Rickaby DA, Krenz GS, Kelly KJ, Kurup VP, Dawson CA: A murine model of latex allergy-induced airway hyperreactivity.Lung 1999, 177:89-100.
22.
Xia J-Q, Rickaby DA, Kelly KJ, Choi HY, Dawson CA, Kurup VP: Immune response and airway reactivity in wild and IL-4 knockout mice exposed to latex allergens.Int Arch Allergy Immunol 1999, 118:23-29.
23.
Kurup VP, Mauze M, Choi H, Seymour BWP, Coffman RL: A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE.J Immunol 1992, 148:3783-3788.
24.
Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, Hansell E, Kurup VP, Warnock M, Grunig G: IL-13 and IFN-γ: Interactions in lung inflammation.J Immunol 2001, 167:1769-1777.
25.
Banerjee B, Kelly KJ, Fink JN, Henderson JD Jr, Bansal NK, Kurup VP: Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis.Infect Immun 2004, 72:6087-6094.
26.
Barrios CS, Johnson BD, Henderson JD Jr, Fink JN, Kelly KJ, Kurup VP: The costimulatory molecules CD80, CD86, and OX40L are up0regulated in Aspergillus fumigatus sensitized mice.Clin Exp Immunol 2005, 142:242-250.
27.
Johnson BD, Kurup VP, Sussman GL, Arif SAM, Kelly KJ, Beezhold DH, Fink JN: Purified and recombinant latex proteins stimulate peripheral blood lymphocytes of latex allergic patients.Int Arch Allergy Immunol 1999, 120:270-279.
28.
Kurup VP, Guo J, Murali PS, Choi HY, Fink JN: Immunopathologic responses to Aspergillus antigen in interleukin-4 knockout mice.J Lab Clin Med 1997, 130:567-575.
29.
Raju R, Dalakas MC: Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIG and biological validation of clinically relevant genes.Brain 2005, 128:1887-1896.
30.
Kurup VP, Fink JN: The spectrum of immunologic sensitization in latex allergy.Allergy 2001, 56:2-12.
31.
Dixon AE, Mandac JN, Madtes DK, Martin PJ, Clark JG: Chemokine expression in Th1 cell-induced lung injury: Prominence of IFN-γ-inducible chemokines.Am J Physiol Lung Cell Mol Physiol 2000, 279:L592-L599.
32.
ten Hacken NHT, Oosterhof Y, Kauffman HF, Guevarra L, Satoh T, Tollerud DJ, Postma DS: Elevated serum interferon -γ in atopic asthma correlates with increased airways responsiveness and circardian peak expiratory flow variation.Eur Respir J 1998, 11:312-316.
33.
Al-shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ: A role for TSLP in the development of inflammation in our asthma model.J Exp Med 2005, 202:829-839.
34.
Gillet M, Vassili S, Watanabe N, Hanabuchi S, Antonenko S, de-Waal-Malefyt R, Liu Y-J: Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells.J Exp Med 2003, 197:1059-1063.
35.
Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, Gyarmati D, Aye T, Campbell DJ, Ziegler SF: Thymic stromal lymphopoietin as key initiator of allergic airway inflammation in mice.Nature Immunol 2005, 6:1047-1053.
36.
Ricciardolo FLM, Zaagsma J, Meurs H: The therapeutic potential of drugs targeting the arginase pathway in asthma.Expert Opinion on Investigational Drugs 2005, 14:1221-1231.
37.
Kurup VP, Raju R, Manickam P: Profile of gene expression in a murine model of allergic bronchopulmonary aspergillosis.Infect Immunity 2005, 73:4381-4384.
38.
Zimmermann N, King NE, LaPorte J, Yang M, Mishra A, Pope SM, Muntel EE, White DP, Pagg AA, Foster PS, Anid QH, Rothenberg ME: Dissection of experimental asthma with DNA microarray analysis identified arginase in asthma pathogenesis.J Clin Invest 2003, 111:1863-1874.
39.
Simonen-Jokinen T, Maisi P, Tervahartiala T, McGorum B, Pirie S: Direct activation of gelatinase B (MMP-9) by haydust suspension and different components of organic dusts.Vet Immunol Immunopath 2006, 109:289-295.
40.
Bharti AC, Donato N, Aggarwal BB: Curcumin (Diferuloylmethane) inhibits constitutive and IL-6 inducible STAT3 phosphorylation in human multiple myeloma cells.J Immunol 2003, 171:3863-3871.
41.
Chan M-Y, Adapala NS, Fong D: Curcumin overcomes the inhibitory effects of nitric oxide on Leishmania.Parasitol Res 2005, 96:49-56
Answers to all your Biology Questions
